Results 21 to 30 of about 3,884 (198)
Atypical lentigo maligna melanoma of the chin: A case report [PDF]
Sabrina Ghalili, MD +5 more
doaj +2 more sources
Resumen: Imiquimod tópico ha sido utilizado como monoterapia o tratamiento adyuvante fuera de indicación para el lentigo maligno (LM). Nuestro objetivo es describir las modalidades de tratamiento, los resultados clínicos y el manejo de la recidiva en los
I. Poveda-Montoyo +4 more
doaj +1 more source
Introduction: Lentigo maligna is a subtype of melanoma in situ that typically affects the head and neck region with an increasing incidence. Margin-controlled techniques, such as spaghetti technique (ST), have gained popularity over wide local excision (
Manel Martinez-Molina +8 more
doaj +1 more source
Sub-Ultraviolet Light Dermoscopy for Surgical Margin Definition in Lentigo Maligna Melanoma [PDF]
Itziar Muelas Rives +5 more
doaj +2 more sources
El lentigo maligno: actualización y claves en el diagnóstico y el tratamiento
Resumen: El lentigo maligno es un melanoma cutáneo in situ que asienta en zonas con daño solar acumulado. Su presentación más habitual es como una mancha irregularmente pigmentada de crecimiento lento y progresivo localizada en la cara de un paciente ...
C. Requena, E. Manrique, E. Nagore
doaj +1 more source
Long-Term Response to Imiquimod for the Treatment of Lentigo Maligna Assessed With Digital Dermoscopy [PDF]
Luisina Caliani, Gabriel Salerni
doaj +2 more sources
Pagetoid spread of melanocytes in the epidermis is a common indicator of melanocytic atypia, both histopathologically and with reflectance confocal microscopy (RCM).
Nadiya Chuchvara +4 more
doaj +1 more source
Accurately identifying the clinical margins of lesions such as lentigo maligna, lentigo maligna melanoma and other non-melanotic skin cancers can often be a clinical challenge.
Joseph Ward +3 more
doaj +1 more source
Dermoscopy Relevance in Eyelid Lentigo Maligna Melanoma [PDF]
Sabina Vaccari +5 more
doaj +2 more sources
Lentigo maligna is a type of in situ melanoma. It develops mainly in middle-aged and elderly individuals on areas of the skin chronically exposed to sunlight. It progresses to its invasive form, lentigo maligna melanoma, in 5% to 50% of cases. Management of lentigo maligna is open to debate, with a notable lack of randomized trials and specific ...
E, Samaniego, P, Redondo
openaire +2 more sources

